Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
Listen to this summary
The evoke and evoke+ trials aimed to evaluate the efficacy and safety of oral semaglutide (14 mg) in individuals with early-stage symptomatic Alzheimer's disease. The results indicated that semaglutide did not significantly slow clinical progression compared to placebo, and while safety profiles were consistent with other indications, the treatment did not demonstrate the expected benefits in this population.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Lancet (London, England)
View all →Mar 24, 2026 · Lancet (London, England)
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
Mar 23, 2026 · Lancet (London, England)
Primary sclerosing cholangitis
Mar 21, 2026 · Lancet (London, England)
Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials
Mar 21, 2026 · Lancet (London, England)
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trial
Mar 21, 2026 · Lancet (London, England)
Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention
Mar 19, 2026 · Lancet (London, England)
More equitable preconception health: paternal life course opportunities for better pregnancy, child, and family outcomes
More in Nuclear Medicine
View all →Mar 25, 2026 · The New England journal of medicine
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
Mar 23, 2026 · The New England journal of medicine
The Inherited Basis of Coronary Artery Disease
Mar 18, 2026 · The New England journal of medicine
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
Mar 17, 2026 · The New England journal of medicine
Prehospital Whole Blood in Traumatic Hemorrhage - a Randomized Controlled Trial
Mar 17, 2026 · The New England journal of medicine
High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure
Mar 11, 2026 · The New England journal of medicine
Polymyalgia Rheumatica
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
